Second Sight Medical enters Russian market
Second Sight Medical (NSDQ:EYES) said today it entered the Russian market, with the 1st patient treated with its Argus II Retinal Prosthesis System in Moscow.
The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception of light patterns to the brain, the Sylmar, Calif.-based company said.
The 1st implant was performed at the Federal State Institution & Clinical Research Center of the Federal Medico-Biological Agency at the end of June 2017 by a team of surgeons, with Dr. Paulo Stanga of the U...
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic second-sight-medical Source Type: news
Researchers use magnetic implants to treat 'dancing eyes'
Scientists are using magnetic implants inserted behind the eye to treat nystagmus, a condition causing involuntary eye movements, or dancing eyes. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 26, 2017 Category: Consumer Health News Source Type: news
Magnets used to control flickering eyes
A case study has shown how magnetic implants in the eye can successfully control the movement of the eye. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 26, 2017 Category: Consumer Health News Source Type: news
7 medtech stories we missed this week: June 23, 2017
[Image from unsplash.com]From Guardant suing Foundation Medicine to Interson receiving 510(k) clearance for ultrasound probes, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. Guardant levels false advertising suit against Foundation Medicine
Guardant Health announced in a June 22 press release that it has filed a lawsuit against Foundation Medicine for false advertising and unfair competition. Guardant Health is claiming that Foundation Medicine’s advertising causes harm to Guardant Health and its patients because it misleads oncologists about the sensitivity and accuracy of the...
Source: Mass Device - June 23, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Food & Drug Administration (FDA) Implants Neurological Regulatory/Compliance Ultrasound EndoStim Foundation Medicine Inc. Guardant Health Interson Lee's Pharmaceutical Meditech Med Source Type: news
Model With Rare Genetic Disorder Is A Brilliant Example Of Inclusion
This world is a diverse one, so it’s refreshing when the fashion industry reflects that reality. And Seattle-based model Melanie Gaydos is hoping to add to that effort.
Gaydos, 28, was born with ectodermal dysplasia, a genetic disorder that can interfere with the proper growth of the hair, nails, teeth, skin and glands. Her involvement in the fashion community is helping people like her to see a place for them in the highly stylized world of modeling.
A post shared by Melanie Gaydos (@melaniegaydos) on May 17, 2017 at 5:12pm PDT
Fewer than 200,000 people in the United States experience the rare condition,...
Source: Healthy Living - The Huffington Post - June 8, 2017 Category: Consumer Health News Source Type: news
2 Massachusetts Women, Thousands Nationwide Say Breast Implants Made Them Sick
BOSTON (CBS) – Just a few months ago, the idea of lacing up her sneakers and going out for a run was impossible for Meghan Sullivan. “It got to a point where I couldn’t get out of bed anymore. I was in that much pain,” she said.
The single mother from Hingham says she broke out into a terrible rash, her face was swollen, she had joint pain and barely had the energy to take care of her 7-year-old son. “It was hard. It was emotional. It was scary for me. I couldn’t live normally,” she said with tears welling up in her eyes.
Kaylee Silcox of Quincy was just 24 when she got sick. “I had joint pain all over,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 10, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local breast implant illness Dr. Mallika Marshall Source Type: news
Second Sight shares drop on Q1 miss
Shares in Second Sight Medical (NSDQ:EYES) have dropped today after the medical device maker missed expectations on Wall Street with its 1st quarter results.
The Sylmar, Calif-based company posted losses of $7.5 million, or 16¢ per share, on sales of $1 million for the 3 months ended March 31, seeing losses grow 29.8% while sales shrunk 4.2% compared with the same period during the prior year.
Analysts on Wall Street were expecting to see losses per share of 14¢, which Second Sight medical came in just above.
“With a focus on execution and our centers of excellence strategy, we had strong implant volume during the ...
Source: Mass Device - May 4, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup second-sight-medical Source Type: news
We Know How To Curb Epidemics. Can Alzheimer's Be Next?
I travel a lot, which means I spend much of my time in airports waiting to catch a flight. I use most of that time to work or catch up on email, but sometimes, when it’s really early in the morning or really late at night, I just sit at the gate and watch the people go by. And not too long ago I saw something that broke my heart.
It was a couple my age, maybe a few years older. They were making their way to the gate. They were ordinary-looking folks, but as I looked at them closely I noticed that something wasn’t quite right. The man seemed confused, disoriented, distressed. The woman seemed stricken, sad. She ...
Source: Healthy Living - The Huffington Post - April 27, 2017 Category: Consumer Health News Source Type: news
PVR and Steroid Implants -- A Good Fit? PVR and Steroid Implants -- A Good Fit?
Have dexamethasone implants changed the treatment landscape of proliferative vitreoretinopathy? Dr Sophie Bakri ' eyes ' the latest research.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 13, 2017 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news
Terumo taps DeRyke as CV CEO | Personnel Moves – April 7, 2017
Terumo Corp. (TYO:4543) said yesterday it tapped Rob DeRyke as its new CV group prez & CEO, effective April 1, 2017, succeeding a retiring Mark Sutter.
Prior to his appointment, DeRyke operated as Terumo CV group electromechanical systems division prez, the company said.
“Under his leadership, Rob brought stability and improved profitability to the business,” Terumo Corp prez & CEO Shinjiro Sato said in a press release.
DeRyke joined Terumo in 2012 as corporate quality VP, and has 25 years of experience in med device and pharmaceuticals, the company said. He has previously held positions at Baxter (N...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: MassDevice staff Tags: Business/Financial News Active Implants AdvaMed Alphatec Holdings Inc. Anika Therapeutics Inc. Apollo Endosurgery Aurora Spine Baxter Biocorp Biogen Idec Biolase Technology Inc Bioventus LLC Bonesupport Clal Biotech Delcath Sys Source Type: news
VisionCare launches new clinical trial for telescope implant
VisionCare, Inc. said this week that the FDA approved its investigational device exemption for a new clinical trial in the U.S. evaluating its telescope implant in patients with end-stage macular degeneration.
The Saratoga, Calif.-based company’s implantable miniature telescope, which was developed by Israeli inventor Dr. Isaac Lipshitz, is contraindicated for patients with previous intraocular or corneal surgery of any kind. This new clinical trial will study the effectiveness of the telescope implant in patients who were previously implanted with an intraocular lens.
“The average patient, at least in North A...
Source: Mass Device - January 13, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Implants Optical/Ophthalmic Surgical VisionCare Ophthalmic Technologies Source Type: news
Reflections on the Future of Medicine
Recently, I traveled through China. I climbed mountains, hiked through forests, crossed deep valleys. I visited cities of every size. I floated across lakes and traveled beautiful shorelines churning with life. As a man of a certain age, I began to compare the permanence of the timeless landscape with the evanescence of my own existence. Yet, as a scientist, I knew these reflections were flawed.
Scientists are trained to think in terms of aeons, millenia, and lifetimes. Consider the paradox. Is it the solid mountain or fragile the forest that is permanent? Is it the massive shoreline cliffs or the teeming shore life that...
Source: Science - The Huffington Post - January 9, 2017 Category: Science Source Type: news
Presbia announces 2-year Microlens data from PMA trial
Presbia (NSDQ:LENS) touted interim data today from its U.S. pivotal clinical trial, which it hopes will eventually support pre-market approval from the FDA for its Flexivue Microlens. The company is 2 years into the 3-year long trial and said that it anticipates submitting final data to the FDA in September 2017.
The company’s lens is intended to correct presbyopia, farsightedness that is often age-related. Presbia’s custom lenses are implanted in the patient’s non-dominant eye in the hopes of helping the patient see near objects more clearly. To place the microlens in a patient’s eye, a small p...
Source: Mass Device - December 23, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Food & Drug Administration (FDA) Implants Optical/Ophthalmic Regulatory/Clearance Presbia Source Type: news
Blind patients to get bionic eyes in 2017: NHS to pay for 10 people to be fitted with eyes
THE NHS will pay for 10 people with an inherited form of blindness to be fitted with "bionic eye" implants. (Source: Daily Express - Health)
Source: Daily Express - Health - December 22, 2016 Category: Consumer Health News Source Type: news
